A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

423

Participants

Timeline

Start Date

July 9, 2015

Primary Completion Date

July 20, 2017

Study Completion Date

July 20, 2017

Conditions
Asthma
Interventions
DRUG

Fluticasone Furoate

FF 92 mcg or 184 mcg blended with lactose administered once daily via ELLIPTA DPI

DRUG

Vilanterol

Vilanterol 22 mcg blended with lactose and magnesium stearate administered once daily via ELLIPTA DPI

DRUG

Fluticasone propionate

FP 250 mcg or 500 mcg blended with lactose administered twice daily via DISKUS DPI

DRUG

Salmeterol

Salmeterol 50 mcg blended with lactose administered twice daily via DISKUS DPI

DRUG

Budesonide

Budesonide 200 mcg or 400 mcg blended with lactose administered twice daily via TURBUHALER DPI

DRUG

Formoterol Fumarate

Formoterol Furoate 6 mcg or 12 mcg blended with lactose administered twice daily via TURBUHALER DPI

Trial Locations (93)

6682

GSK Investigational Site, Teuchern

10119

GSK Investigational Site, Berlin

10717

GSK Investigational Site, Berlin

10787

GSK Investigational Site, Berlin

11100

GSK Investigational Site, Narbonne

13156

GSK Investigational Site, Berlin

13331

GSK Investigational Site, Marseille

13420

GSK Investigational Site, Gémenos

14000

GSK Investigational Site, Caen

14059

GSK Investigational Site, Berlin

14469

GSK Investigational Site, Potsdam

19300

GSK Investigational Site, Rosiers-d'Égletons

21000

GSK Investigational Site, Dijon

21502

GSK Investigational Site, Geesthacht

24660

GSK Investigational Site, Coulounieix-Chamiers

27270

GSK Investigational Site, Broglie

31077

GSK Investigational Site, Toulouse

31300

GSK Investigational Site, Toulouse

31700

GSK Investigational Site, Beauzelle

33560

GSK Investigational Site, Carbon-Blanc

33780

GSK Investigational Site, Soulac-sur-Mer

34070

GSK Investigational Site, Montpellier

34295

GSK Investigational Site, Montpellier

34500

GSK Investigational Site, Béziers

34660

GSK Investigational Site, Cournonterral

35340

GSK Investigational Site, La Bouëxière

35460

GSK Investigational Site, Saint-Ouen-la-Rouërie

35800

GSK Investigational Site, Dinard

35890

GSK Investigational Site, Bourg-des-Comptes

37520

GSK Investigational Site, La Riche

39120

GSK Investigational Site, Magdeburg

40180

GSK Investigational Site, Hinx

42000

GSK Investigational Site, Saint-Etienne

42100

GSK Investigational Site, Saint-Etienne

44200

GSK Investigational Site, Nantes

44263

GSK Investigational Site, Dortmund

44300

GSK Investigational Site, Nantes

44480

GSK Investigational Site, Donges

48431

GSK Investigational Site, Rheine

49000

GSK Investigational Site, Angers

49370

GSK Investigational Site, Bécon-les-Granits

49500

GSK Investigational Site, Segré

49610

GSK Investigational Site, Mûrs-Erigné

51380

GSK Investigational Site, Verzy

51420

GSK Investigational Site, Witry-lès-Reims

53000

GSK Investigational Site, Laval

54000

GSK Investigational Site, Nancy

54170

GSK Investigational Site, Colombey-les-Belles

54200

GSK Investigational Site, Royaumeix

GSK Investigational Site, Toul

54710

GSK Investigational Site, Fléville-devant-Nancy

54840

GSK Investigational Site, Gondreville

59130

GSK Investigational Site, Lambersart

59150

GSK Investigational Site, Wattrelos

59235

GSK Investigational Site, Bersée

59287

GSK Investigational Site, Guesnain

59690

GSK Investigational Site, Vieux-Condé

59710

GSK Investigational Site, Avelin

62160

GSK Investigational Site, Grenay

62700

GSK Investigational Site, Bruay-la-Buissière

64200

GSK Investigational Site, Bassussarry

GSK Investigational Site, Biarritz

66000

GSK Investigational Site, Perpignan

67000

GSK Investigational Site, Strasbourg

67210

GSK Investigational Site, Obernai

67690

GSK Investigational Site, Hatten

68600

GSK Investigational Site, Dessenheim

74370

GSK Investigational Site, Metz-Tessy

75020

GSK Investigational Site, Paris

76000

GSK Investigational Site, Rouen

79100

GSK Investigational Site, Thouars

79380

GSK Investigational Site, La Fôret Sur Sèvres

80090

GSK Investigational Site, Amiens

80339

GSK Investigational Site, Munich

81241

GSK Investigational Site, Munich

82017

GSK Investigational Site, Montauban

83000

GSK Investigational Site, Toulon

86100

GSK Investigational Site, Châtellerault

86140

GSK Investigational Site, Scorbé-Clairvaux

87000

GSK Investigational Site, Limoges

93150

GSK Investigational Site, Le Blanc-Mesnil

94574

GSK Investigational Site, Wallerfing

94800

GSK Investigational Site, Villejuif

95124

GSK Investigational Site, Ermont

06614

GSK Investigational Site, Cannes

06000

GSK Investigational Site, Nice

04509

GSK Investigational Site, Delitzsch

04109

GSK Investigational Site, Leipzg

04103

GSK Investigational Site, Leipzig

04207

GSK Investigational Site, Leipzig

04275

GSK Investigational Site, Leipzig

04357

GSK Investigational Site, Leipzig

04626

GSK Investigational Site, Schmölln

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02446418 - A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma | Biotech Hunter | Biotech Hunter